1,058 results on '"Ohyama, C."'
Search Results
152. 279P Quality of life during gemcitabine plus cisplatin or gemcitabine plus carboplatin for urothelial carcinoma
153. 278P Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for advanced upper-tract urothelial cancer patient with impaired renal function
154. A Retrospective Analysis of the Relationship Between Prescribed Dose and Dosimetric Advantage Taken by Intraoperative Built Custom Linked Seeds in Iodine-125 Prostate Brachytherapy
155. Efficacy and safety of nivolumab monotherapy in patients with metastatic urothelial cancer (mUC) who have received prior treatment: Results from the phase II CheckMate 275 study
156. Safety and Effectiveness of Marginal Donor in Living Kidney Transplantation
157. 249 Cell surface branching glycan regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling
158. 250 Role of anti-metastatic laminin-binding O-glycan on α-dystroglycan regulated by miR-X in prostate cancer
159. 255 PD-L1 expression in prostate cancer
160. 333 Slow gait speed and rapid renal function decline are risk factors for postoperative delirium after urological surgery
161. 794 Stabilization of invadopodia by plectin-mediated conjunction to vimentin intermediate filament is a critical molecular step of invasion and extravasation for metastasis in bladder cancer
162. 801 The impact of ureteral ligation on clinical outcome during radical nephroureterectomy for upper urinary tract urothelial carcinoma: Multi-institutional case series study JCOG1110A
163. 486 The implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism
164. 604 Serum N-glycan profiling predict antibody mediated rejection in patients undergoing living kidney transplantation
165. 912 The impact of uric acid stone components on renal function deterioration
166. 249P - The gap of frailty value from a community-dwelling population predict oncological outcomes in patients with urological cancers
167. 241P - Does neoadjuvant chemotherapy promote chemoresistance after recurrence in patients with muscle-invasive bladder cancer?
168. 236P - The relationship between preoperative stage IIIB chronic kidney disease and post-surgical oncological outcomes in patients with urothelial carcinoma
169. 226P - Aldo-keto-reductase 1C3 expression in prostate cancer
170. 215P - Comparison between robot-assisted radical prostatectomy and minimum incision endoscopic radical prostatectomy for high-risk prostate cancer following neoadjuvant therapy: A propensity score-matched analysis
171. 1030 - The impact of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A multicenter study
172. 1018 - Regional distribution of lymph node metastasis in upper urinary tract urothelial cancer, sub-analysis of large multi-institutional study (JCOG1110A)
173. 1020 - Clinical implication of bacillus Calmette-Guérin (BCG) perfusion therapy in patients with carcinoma in situ (CIS) of the upper urinary tract: A comparison with nephroureterectomy
174. 940 - A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I in bladder cancer
175. 844 - Association of frailty and lower urinary tract symptoms: Results from the Iwaki health promotion project in Japan
176. 814 - Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution
177. 704 - Relationship between postoperative weight loss and oncological outcomes after radical cystectomy
178. 532 - Serum aberrant N-glycan profile as a marker associated with early antibody-mediated rejection in patients receiving a living donor kidney transplant
179. 245 - Association of nocturia, sleep disorder, and quality of life in community-dwelling population: Results from Iwaki health promotion project in Japan
180. 246 - Survey on lower urinary tract symptoms, sleep disorders, and oxidase stress in community-dwelling population: Results from Iwaki health promotion project in Japan
181. 200 - Clinical implication of a simple quantitative frailty assessment tool for prognosis in patients with urological cancers
182. 98 - Risk factors for symptomatic recurrence after radical cystectomy in patients with locally advanced bladder cancer
183. 18 - Patient selection for confirmatory tests of primary aldosteronism (PA) using the PA discrimination score
184. 15 - MECA-79-positive high endothelial venule density may associate with pheochromocytoma aggressiveness
185. 536 Neoadjuvant gemcitabine and carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer patients ineligible for cisplatin-based chemotherapy: A propensity score-matched analysis
186. 657 Slow gait speed predict of post-operative delirium in elderly patients
187. 521 Detection of core2 β-1,6-N-acetylglucosaminyltransferase in post-digital rectal examination urine is an independent predictor for extraprostatic extension of prostate cancer
188. 169 Role of laminin receptors for perineural invasion in prostate cancer
189. 1020 Both radical prostatectomy with neoadjuvant LHRH agonist and estramustine and radiotherapy with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: A propensity-score matching analysis
190. 653 Postchemotherapy AKR1B10 expression correlates with disease-free survival in muscle-invasive bladder cancer
191. 429 Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer
192. 203 Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy
193. 1044 Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan
194. 655 Early detection of asymptomatic visceral recurrence after radical cystectomy contributes better prognosis in patients with muscle invasive bladder cancer
195. 726 Impact of aortic calcification burden on renal function recovery in RCC
196. 272O - Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: A multicenter study
197. 278P - MECA79 positive high endothelial venule density (HEV) correlates with clinical outcomes in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
198. 675 - Gait speed is a useful tool to evaluate frailty in urological cancer patients
199. 536 - A randomized, open-label, multicenter study evaluating efficacy of switch from dutasteride to tadalafil in benign prostatic hyperplasia patient with lower urinary tract symptoms (D-to-T trial)
200. 526 - Bladder cancer-secreted extracellular vesicles destroy vascular endothelial barriers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.